Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Prosser

Showing results (331-340 of 343) with videos related to

Pageof 35
Sort By:
JAMA Network Open|August 7, 2025
Cost-Effectiveness of 2023-2024 COVID-19 Vaccination in US AdultsLisa A Prosser, Megan Wallace, Angela M Rose, et al.
Pharmacoeconomics|December 2, 2023
Recommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task ForceEdward Henry, Hareth Al-Janabi, Werner Brouwer, et al.
NIH Consensus and State-Of-The-Science Statements|June 11, 2013
NIH consensus development conference: diagnosing gestational diabetes mellitusJames P Vandorsten, William C Dodson, Mark A Espeland, et al.
JAMA|September 14, 2016
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and MedicineGillian D Sanders, Peter J Neumann, Anirban Basu, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3Maria R Abbattista, Amir Ashoorzadeh, Christopher P Guise, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 25, 2018
Future Directions for Cost-effectiveness Analyses in Health and MedicinePeter J Neumann, David D Kim, Thomas A Trikalinos, et al.
Contemporary Clinical Trials|August 5, 2021
Optimizing scalable, technology-supported behavioral interventions to prevent opioid misuse among adolescents and young adults in the emergency department: A randomized controlled trial protocolErin E Bonar, Kelley M Kidwell, Amy S B Bohnert, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 22, 2018
Automated symptom and treatment side effect monitoring for improved quality of life among adults with diabetic peripheral neuropathy in primary care: a pragmatic, cluster, randomized, controlled trialA S Adams, J A Schmittdiel, A Altschuler, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2026
Identification and Evaluation of dibasic piperidines as novel cell wall inhibitors against <i>Mycobacterium tuberculosis</i>Claire Naylor, Gareth A Prosser, Tracy Bayliss, et al.
Eclinicalmedicine|July 30, 2025
Towards universal early screening for cerebral palsy: a roadmap for automated General Movements AssessmentAlicia J Spittle, Peter B Marschik, Lars Adde, et al.
Pageof 35

Showing results (331-340 of 343) with videos related to

Sort By:
Pageof 35
JAMA Network Open|August 7, 2025
Cost-Effectiveness of 2023-2024 COVID-19 Vaccination in US AdultsLisa A Prosser, Megan Wallace, Angela M Rose, et al.
Pharmacoeconomics|December 2, 2023
Recommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task ForceEdward Henry, Hareth Al-Janabi, Werner Brouwer, et al.
NIH Consensus and State-Of-The-Science Statements|June 11, 2013
NIH consensus development conference: diagnosing gestational diabetes mellitusJames P Vandorsten, William C Dodson, Mark A Espeland, et al.
JAMA|September 14, 2016
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and MedicineGillian D Sanders, Peter J Neumann, Anirban Basu, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3Maria R Abbattista, Amir Ashoorzadeh, Christopher P Guise, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 25, 2018
Future Directions for Cost-effectiveness Analyses in Health and MedicinePeter J Neumann, David D Kim, Thomas A Trikalinos, et al.
Contemporary Clinical Trials|August 5, 2021
Optimizing scalable, technology-supported behavioral interventions to prevent opioid misuse among adolescents and young adults in the emergency department: A randomized controlled trial protocolErin E Bonar, Kelley M Kidwell, Amy S B Bohnert, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 22, 2018
Automated symptom and treatment side effect monitoring for improved quality of life among adults with diabetic peripheral neuropathy in primary care: a pragmatic, cluster, randomized, controlled trialA S Adams, J A Schmittdiel, A Altschuler, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2026
Identification and Evaluation of dibasic piperidines as novel cell wall inhibitors against <i>Mycobacterium tuberculosis</i>Claire Naylor, Gareth A Prosser, Tracy Bayliss, et al.
Eclinicalmedicine|July 30, 2025
Towards universal early screening for cerebral palsy: a roadmap for automated General Movements AssessmentAlicia J Spittle, Peter B Marschik, Lars Adde, et al.
Pageof 35